Uzma D. Siddiqui to Esophageal Neoplasms
This is a "connection" page, showing publications Uzma D. Siddiqui has written about Esophageal Neoplasms.
Connection Strength
1.800
-
Efficacy, Durability, and Safety of Complete Endoscopic Mucosal Resection of Barrett Esophagus: A Systematic Review and Meta-Analysis. J Clin Gastroenterol. 2018 03; 52(3):210-216.
Score: 0.524
-
A rare cause of dysphagia. Gastroenterology. 2010 Jul; 139(1):e3-4.
Score: 0.308
-
Real-world evidence of safety and effectiveness of Barrett's endoscopic therapy. Gastrointest Endosc. 2023 08; 98(2):155-161.e1.
Score: 0.186
-
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease. Cancer Discov. 2021 02; 11(2):308-325.
Score: 0.158
-
Perceptions of risk and therapy among patients with Barrett's esophagus: a patient survey study. Dis Esophagus. 2018 Apr 01; 31(4).
Score: 0.132
-
Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma. Cancer Discov. 2018 01; 8(1):37-48.
Score: 0.127
-
Use of narrow-band imaging with magnification to predict depth of invasion of early esophageal squamous cell cancer and to guide endoscopic therapy. Gastrointest Endosc. 2015 Feb; 81(2):469-70; discussion 470.
Score: 0.104
-
A single-center experience of endoscopic submucosal dissection performed in a Western setting. Dig Dis Sci. 2015 Feb; 60(2):531-6.
Score: 0.102
-
Complete endoscopic mucosal resection is effective and durable treatment for Barrett's-associated neoplasia. Clin Gastroenterol Hepatol. 2014 Dec; 12(12):2002-10.e1-2.
Score: 0.100
-
Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial. JAMA Netw Open. 2020 02 05; 3(2):e1921290.
Score: 0.037
-
Endoscopic closure devices. Gastrointest Endosc. 2012 Aug; 76(2):244-51.
Score: 0.022